Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03173586 · ClinicalTrials.gov registry record
Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women
A clinical trial, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- 33,000
- Enrollment target
NCT03173586: Completed study, sponsored by Harvard School of Public Health (HSPH).
NCT03173586 is a clinical trial that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 33,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03173586 has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- 33,000 participants
- Enrollment target
Study Summary
This study is a secondary analysis of data collected in the Nurses' Health Study (NHS) that will evaluat the association between intake of sugar sweetened beverages (SSB), juice and artificially sweetened beverages in relation to biomarkers of hepatic function, lipid metabolism, inflammation and glycemic control.
Primary Outcome
Biomarkers of liver function
Interventions
- OTHER Sugar sweetened beverage (SSB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33,000 participants |
| Start Date | 1999-09-16 |
| Est. Completion | 2009-03-31 |
What the finished NCT03173586 record still lists
NCT03173586 is an observational study that tracks outcomes without assigning an intervention. Its 33,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Sugar sweetened beverage (SSB) is the first listed.
NCT03173586 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03173586 about?
NCT03173586 is a clinical study titled "Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women". This study is a secondary analysis of data collected in the Nurses' Health Study (NHS) that will evaluat the association between intake of sugar sweetened beverages (SSB), juice and artificially sweetened beverages in relation to biomarkers of hepatic function, lipid metabolism, inflammation and gly...
What is the current status of trial NCT03173586?
This trial is currently completed. The enrollment target is 33,000 participants. The study started on 1999-09-16. Estimated completion is 2009-03-31.
What interventions are being tested in trial NCT03173586?
The interventions under investigation include: Sugar sweetened beverage (SSB) (OTHER).
Who is sponsoring clinical trial NCT03173586?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04477928 · 33,000 participants
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
- NCT06145724 · 33,183 participants · NA
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
- NCT07282665 · 32,000 participants · Phase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI